Painreform is trading 5.08% up at $1.08 after opening-market strength on August 13, 2026, though the immediate driver remains unclear.
- No reliable company-specific announcement, earnings release, regulatory action, or other direct catalyst has been identified.
- Broader risk-on sentiment may be providing support as major U.S. indices trade higher.
- Available coverage reports no recent press releases.